Home
Tools
TRIPS Flexibilities Database
Resources
Blog
About

Search

Medicines Law & Policy Research and resources on intellectual property and health

Home
Tools
TRIPS Flexibilities Database
Resources
Blog
About

Tag: SPC

CJEU Ruling on Truvada recalls ‘evergreening’ goes against public health interests

Pascale Boulet - September 10, 2018

Recent Posts

Are gene-editing therapies patentable? A WIPO side event investigates.
New Database Documents the Power of TRIPS Flexibilities
New Tool Maps Use of TRIPS Flexibilities for Public Health
WIPO and pharma industry launch global medicines patent database

Posts by Subject

Access to Medicines Cancer CDCA competition law Compulsory licensing compulsory licensing for export CRISPR Data exclusivity Delinkage dolutegravir EMA European Commission European Court European Union evergreening France Gilead Hepatitis C HIV India innovation Italy LDCs market exclusivity Medicines Patent Pool Medicines Pricing Netherlands Orphan Drugs Patents PrEP R&D rare diseases Scotland Seroquel Sofosbuvir Spain SPC Supplementary Protection Certificates TRIPS flexibilities Truvada United Kingdom United Nations High Level Panel WHO WIPO WTO

Medicines Law & Policy releases analysis, policy recommendations and tools to aid practitioners working on universal access to medicines. We strive to provide information that is as accurate as possible, and we welcome and encourage feedback. For comments or questions contact us at: info@medicineslawandpolicy.net.

This work is licensed under Creative Commons.